In a model of Id-specific CD4+ T cell responses against an MHC IIPOS B lymphoma, in vitro cytotoxicity was shown to be dependent on signaling mediated by binding of Fas ligand (FasL) on CD4+ T cells to the death receptor Fas on tumor cells (66). The gene discussed is CD4; the disease is neoplasm.